Glioblastoma-Amplified Sequence (GBAS) Antibody

REQUEST MORE INFO
Catalogue No: abx032970
Price: US$326.25
(Size: 80 µl)

Orders to United States ship from United States

Glioblastoma-Amplified Sequence (GBAS) Antibody Glioblastoma-Amplified Sequence (GBAS) Antibody Glioblastoma-Amplified Sequence (GBAS) Antibody

Click on the image to see the image legend

Available Options

* Size:


Add to Shopping Cart Buy It Now GET A QUOTE

Documents

Datasheet SDS
Chromosomal region 7p12, which contains GBAS, is amplified in approximately 40% of glioblastomas, the most common and malignant form of central nervous system tumor.The predicted 286-amino acid protein contains a signal peptide, a transmembrane domain, and 2 tyrosine phosphorylation sites. The GBAS transcript is expressed most abundantly in heart and skeletal muscle. GBAS protein might be involved in vesicular transport.

Target Glioblastoma-Amplified Sequence (GBAS)
Clonality Polyclonal
Reactivity Human
Tested Applications ELISA, WB, IHC, FCM
Host Rabbit
Recommended dilutions WB: 1/1000, IHC-P: 1/50 - 1/100, FCM: 1/10 - 1/50. Not tested in IHC-F. Optimal dilutions/concentrations should be determined by the end user.
Conjugation Unconjugated
Immunogen KLH-conjugated synthetic peptide between 130-159 amino acids from the Central region of human GBAS.
Isotype IgG
Form Liquid
Purification Purified through a protein A column, followed by peptide affinity purification.
Storage Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
UniProt Primary AC O75323 (UniProt, ExPASy)
UniProt Secondary AC C9IYJ3, O43801, Q53X96
UniProt Entry Name NIPS2_HUMAN
Gene Symbol NIPSNAP2
KEGG hsa:2631
String 9606.ENSP00000313050
Molecular Weight Calculated MW: 33.7 kDa
Buffer PBS containing 0.09% sodium azide.
Availability Shipped within 5-10 working days.
Note THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Research Articles on Glioblastoma-Amplified Sequence (GBAS)


Write a review